Diagnostic Accuracy of Magnetic Resonance Imaging in Carcinoma of Cervix Taking Histopathology as Gold Standard
Magnetic Resonance Imaging in Carcinoma of Cervix Taking Histopathology as Gold Standard
DOI:
https://doi.org/10.54393/pbmj.v5i6.548Keywords:
Cervical carcinoma, pelvic lymph node metastasis, Histopathological examination (HPE)Abstract
The crucial factor that plays important role in diagnosis and prompt treatment management of cervical cancer is staging. To stage cervical carcinoma Magnetic Resonance Imaging (MRI) is considered to be the most accurate and gold standard diagnostic tool. Objective: The aim of the present study was to elaborate the diagnostic accuracy of MRI in correlation with Histopathological Examination (HPE). Methods: The 53 patients diagnosed with cervical carcinoma attending the gynecology department of hospital from May 2021 to April 2022 were included in the study. Those patients who had undergone the abdomen and pelvis MRI fulfilled the inclusion criteria. The MRI and histopathological examination not only help in staging of cancer but also consider valuable in tracking tumor location, size and extension. The retroperitoneal lymphadenopathy, and involvement of the tumor to the adjacent areas was also evaluated by the study. Staging of all patient was done according to the International Federation of Gynecology and Obstetrics FIGO standards. Findings of MRI and HPE were assessed. For statistical evaluation of data, the SPSS version 22.0 was used. For quantitative variables the values were represented as mean with standard deviations. Results: The 54.46±9.29 years was the calculated mean age. Squamous cell carcinoma was diagnosed in almost 46 patients (87.5% cases). Stage IB carcinoma was diagnosed in almost 47.91% cases. Pelvic lymphadenopathy was observed in 8.34% cases, while metastasis of pelvic nodal lymph was observed in 4.16% cases on the HPE. Conclusion: Malignant diseases require early and accurate tool for their diagnosis. For identification of cancer stage and better planning of treatment of cervical carcinoma the highly non-invasive modality MRI can be used. With the advents in MR imaging, it is considered as gold standard diagnostic tool with better sensitivity, specificity and high accuracy for cervical carcinoma.
References
Yogaraj K. Association between MRI Findings and Histopathological Examination in Carcinoma Cervix: A Retrospective Study. International Journal of Anatomy, Radiology and Surgery. 2021 Apr; 10(2): 61-4. DOI: 10.7860/IJARS/2021/46070:2642
Unni N, MN B, Thomas S, Puthussery PV. Diagnostic Accuracy in Staging of Carcinoma Cervix Using Magnetic Resonance Imaging versus Clinical Staging. Journal of medical science and clinical research. 2019 Jun; 7(6) :371-6. DOI: https://dx.doi.org/10.18535/jmscr/v7i6.64
Kalaivani C. Role of MR Imaging in Diagnosis, Staging and Follow Up of Patients with Carcinoma Cervix (Doctoral dissertation, Coimbatore Medical College, Coimbatore). 2019.
Vani CK, Murali N, Sundari N. Role of Magnetic resonance imaging in diagnosis, staging and follow up of patients with carcinoma cervix. International Journal of Radiology and Diagnostic Imaging 2020; 3(2): 101-6. DOI: http://dx.doi.org/10.33545/26644436.2020.v3.i2b.105
Sood M, Boricha A, Trivedi A, Dodiya C. Magnetic Resonance Imaging in Carcinoma of Cervix. IOSR Journal of Dental and Medical Sciences (IOSR-JDMS). 2018 Sep; 17(9): 23-9. DOI: 10.9790/0853-1709032329
Shahbaz S. Diagnostic Accuracy of Magnetic Resonance Imaging in Carcinoma of Cervix Taking Histopathology as Gold Standard. Pakistan Journal of Radiology. 2020 Feb; 29(4).
Kumari A, Pankaj S, Nazneen S, Kumari J, Kumari A, Choudhary V, et al. Diagnostic Accuracy of MRI with Clinical Staging in Cervical Cancer. Journal of Indira Gandhi Institute of Medical Sciences. 2019 Jan; 5(1):17.
Zubery MH, Rahman FB, Islam MN, Datta A, Rahman T, Mahdi R. A Comparative Study between Magnetic Resonance Imaging and Clinical FIGO Criteria in Different Stages of Carcinoma Cervix. Mymensingh medical journal: MMJ. 2021 Oct; 30(4):1131-8.
Anand AS, Abraham MM, Kuriakose VG. MRI versus clinical assessment in staging and response evaluation in locally advanced cervix cancer patients treated with concurrent chemo-radiation in a tertiary cancer center: a prospective study. International Journal of Reproduction, Contraception, Obstetrics and Gynecology. 2017 Feb; 6(2):393. doi.org/10.18203/2320-1770.ijrcog20164826
Mahajan A, Sable NP, Popat PB, Bhargava P, Gangadhar K, Thakur MH, et al. Magnetic Resonance Imaging of Gynecological Malignancies: Role in Personalized Management. Semin Ultrasound CT MR. 2017 Jun; 38(3):231-268. doi: 10.1053/j.sult.2016.11.005.
Tsikouras P, Zervoudis S, Manav B, Tomara E, Iatrakis G, Romanidis C, et al. Cervical cancer: screening, diagnosis and staging. J buon. 2016 Mar 1; 21(2):320-5.
Jenkins D. Histopathology and cytopathology of cervical cancer. Disease Markers. 2007;23(4):199-212. doi: 10.1155/2007/874795.
Shweel MA, Abdel-Gawad EA, Abdel-Gawad EA, Abdelghany HS, Abdel-Rahman AM, Ibrahim EM. Uterine cervical malignancy: diagnostic accuracy of MRI with histopathologic correlation. Journal of clinical imaging science.2012; 2:42. doi: 10.4103/2156-7514.99175.
Zand KR, Reinhold C, Abe H, Maheshwari S, Mohamed A, Upegui D. Magnetic resonance imaging of the cervix. Cancer Imaging. 2007 May; 7(1):69-76. doi: 10.1102/1470-7330.2007.0011
Devine C, Gardner C, Sagebiel T, Bhosale P. Magnetic resonance imaging in the diagnosis, staging, and surveillance of cervical carcinoma. InSeminars in Ultrasound, CT and MRI. WB Saunders. 2015 Aug; 36(4): 361-8.
Rockall AG, Ghosh S, Alexander-Sefre F, Babar S, Younis MT, Naz S, et al.Can MRI rule out bladder and rectal invasion in cervical cancer to help select patients for limited EUA? Gynecologic Oncology. 2006 May; 101(2):244-9. doi: 10.1016/j.ygyno.2005.10.012.
REHMAN WU, FAYAZ M. Magnetic Resonance Imaging: A Useful Tool for Diagnosing Malignancy-Diagnostic Accuracy of MRI in Detection of Malignancy of Cervix. Diabetes. 30:20-0.
Choi SH, Kim SH, Choi HJ, Park BK, Lee HJ. Preoperative magnetic resonance imaging staging of uterine cervical carcinoma: results of prospective study. Journal of computer assisted tomography. 2004 Sep-Oct; 28(5):620-7. doi: 10.1097/01.rct.0000138007.77725.0a.
Liu X, Wang J, Hu K, Zhang F, Meng Q, Wang W, et al. Validation of the 2018 FIGO Staging System of Cervical Cancer for Stage III Patients with a Cohort from China. Cancer Management and Research. 2020 Feb; 12:1405-1410. doi: 10.2147/CMAR.S239624.
Bhatla N, Aoki D, Sharma DN, Sankaranarayanan R. Cancer of the cervix uteri. International Journal of Gynaecology and Obstetrics. 2018 Oct;143 Suppl 2:22-36. doi: 10.1002/ijgo.12611.
Cohen PA, Jhingran A, Oaknin A, Denny L. Cervical cancer. Lancet. 2019 Jan 12;393(10167):169-82. doi: 10.1016/S0140-6736(18)32470-X.
Vizcaino AP, Moreno V, Bosch FX, Muñoz N, Barros-Dios XM, Borras J, et al. International trends in incidence of cervical cancer: II. Squamous-cell carcinoma. International Journal of Cancer. 2000 May; 86(3):429-35. doi: 10.1002/(sici)1097-0215(20000501)86:3<429: aid-ijc20>3.0.co;2-d.
Boss EA, Barentsz JO, Massuger LF, Boonstra H. The role of MR imaging in invasive cervical carcinoma. European radiology. 2000 Jan;10(2):256-70. doi.org/10.1007/s003300050042
Patel-Lippmann K, Robbins JB, Barroilhet L, Anderson B, Sadowski EA, Boyum J. MR imaging of cervical cancer. Magnetic Resonance Imaging Clinics. 2017 Aug 1;25(3):635-49. doi.org/10.1016/j.mric.2017.03.007
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Pakistan BioMedical Journal
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments editor@pakistanbmj.com
